{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:14:14Z","timestamp":1777418054969,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.atherosclerosis.2023.117364","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T07:10:40Z","timestamp":1699254640000},"page":"117364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia"],"prefix":"10.1016","volume":"386","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-3585","authenticated-orcid":false,"given":"Rafael","family":"Zubir\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsenio","family":"Vargas-Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola Del Razo","family":"Olvera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivette","family":"Cruz-Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandro","family":"Martag\u00f3n-Rosado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Aguilar-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.117364_bib1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib2","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low-density lipoprotein subclass patterns and risk of myocardial infarction","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib5","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib7","first-page":"224","article-title":"Familial combined hyperlipidemia: current knowledge, perspectives, and controversies","volume":"70","author":"Bello-Chavolla","year":"2018","journal-title":"Rev. Investig. Clin. Organo Hosp. Enfermedades Nutr."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cca.2014.08.018","article-title":"Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia","volume":"438","author":"Cruz-Bautista","year":"2015","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib9","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of Blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.935257","article-title":"Identification of dysbetalipoproteinemia by an enhanced sampson-NIH equation for very low-density lipoprotein-cholesterol","volume":"13","author":"Sampson","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib11","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/biomedicines10123156","article-title":"Accuracy and clinical impact of estimating low-density lipoprotein-cholesterol at high and low levels by different equations","volume":"10","author":"Sampson","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/10408363.2020.1745142","article-title":"The clinical and laboratory investigation of dysbetalipoproteinemia","volume":"57","author":"Boot","year":"2020","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MOL.0000000000000127","article-title":"Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB","volume":"25","author":"Sniderman","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cjca.2020.03.020","article-title":"Pediatric dyslipidemia-beyond familial hypercholesterolemia","volume":"36","author":"Lazarte","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12944-021-01471-3","article-title":"Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations","volume":"20","author":"Vargas-V\u00e1zquez","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.mol.0000226121.27931.3f","article-title":"Genetics of familial combined hyperlipidemia","volume":"17","author":"Naukkarinen","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jacc.2013.01.079","article-title":"Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications","volume":"62","author":"Martin","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjcard.2015.05.013","article-title":"Reliability of calculated low-density lipoprotein cholesterol","volume":"116","author":"Meeusen","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.atherosclerosis.2018.06.868","article-title":"Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia","volume":"277","author":"Mehta","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib20","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.jacc.2020.09.610","article-title":"VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins","volume":"76","author":"Balling","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib21","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","article-title":"PCSK9: from basic science discoveries to clinical trials","volume":"122","author":"Shapiro","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/2047487315569411","article-title":"Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C","volume":"22","author":"Pencina","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib23","first-page":"313","article-title":"[Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia]","volume":"85","author":"Pei","year":"2005","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MED.0000000000000389","article-title":"Discordance between lipoprotein particle number and cholesterol content: an update","volume":"25","author":"Cantey","year":"2018","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCULATIONAHA.119.041149","article-title":"Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease","volume":"140","author":"Welsh","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib27","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","article-title":"Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men","volume":"112","author":"Pischon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.117364_bib29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1373\/clinchem.2016.264515","article-title":"Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women","volume":"63","author":"Lawler","year":"2017","journal-title":"Clin. Chem."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T01:29:19Z","timestamp":1701998959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023052851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"alternative-id":["S0021915023052851"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117364","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117364"}}